首页> 中文期刊> 《亚太热带医药杂志(英文版)》 >Isolation, fractionation and evaluation of the antiplasmodial properties of Phyllanthus niruri resident in its chloroform fraction

Isolation, fractionation and evaluation of the antiplasmodial properties of Phyllanthus niruri resident in its chloroform fraction

         

摘要

Objective:To investigate the antiplasmodial activity ofPhyllanthus niruri(P. niruri) methanol extract(ME) and its fractions in mice.Methods:P. niruri methanol extract and its chloroform, ethanol and aqueous portions were tested against chloroquine-sensitivePlasmodium berghei bergheiin early, established and repository models of infection usingKnight andPeter's4-day suppressive model,Ryley andPeters curative model andPeters prophylactic model respectively. Results:Chemosuppression of parasitaemia(37.65%-50.53%) was elicited by100-400 mg/kg(b.w.) ofME.At doses of100 mg/kg b.w., the chloroform fraction(F1) significantly(P<0.01) suppressed parasitaemia by85.29%, while ethanol and aqueous fractions(F2 andF3, respectively) elicited 67.06% and51.18% chemosuppression.The most active fraction,F1 was selected for further antiplasmodial screening.Inestablished infection,ME reduced parasitaemia(15.81% -62.96%) whileF1 significantly(P<0.01) reduced parasitaemia(44.36%-90.48%), with effects comparable to that of chloroquine(96.48%).The prophylactic antiplasmodial activity ofME(92.50% suppression) was also significant(P<0.01) and was more effective than pyrimethamine(85.00%).Additionally, cell membrane integrity of non-parasitizederythrocytes incubated with125-500 mg/mLF1 was maintained.Conclusions:These findings indicate the antiplasmodial efficacy ofP. niruri methanol extract, and the localization of this effect in its chloroform fraction.

著录项

  • 来源
    《亚太热带医药杂志(英文版)》 |2013年第3期|169-175|共7页
  • 作者单位

    Department of Pharmacology and Toxicology, National Institute for Pharmaceutical Research and Development, P.M.B. 21, Abuja, Nigeria;

    Department of Medicinal Plant Research and Traditional Medicine, National Institute for Pharmaceutical Research and Development, P.M.B. 21, Abuja, Nigeria;

    Department of Microbiology and Biotechnology, National Institute for Pharmaceutical Research and Development, P.M.B. 21, Abuja, Nigeria;

    Department of Pharmacology and Toxicology, National Institute for Pharmaceutical Research and Development, P.M.B. 21, Abuja, Nigeria;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号